The pharmaceutical sector is undergoing significant transformation, marked by the increasing integration of Big Data and Artificial Intelligence (AI). This evolution is catalyzed by initiatives such as those from Synapse Medicine, which recently launched an AI platform to optimize medication usage. The market is also witnessing a gradual adoption of Big Data, promising to revolutionize current practices and optimize services. However, this technological transition raises questions about the implications for SMEs and very small businesses, particularly in terms of costs, training, and regulatory compliance.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
